The Recall Desk
ModerateFDA (Drugs)·D-0326-2023·Announced 2023-02-22

FDA Recalls Humatrix Microclysmic Gel for Manufacturing Practice Violations

Consolidated Chemical, Inc. is recalling 3186 bottles of Humatrix Microclysmic Gel nationwide due to deviations from proper manufacturing practices.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall for manufacturing practice deviations without reported illnesses, injuries, or specific contamination identified in the source. The precautionary nature and absence of reported consumer harm support a Moderate classification.

Plain-English summary

Consolidated Chemical, Inc. is recalling 3186 bottles of Humatrix Microclysmic Gel, 8 oz per bottle, distributed nationwide in the United States. The affected product includes Lot 3216 (expiring April 2023) and Lot 3218 (expiring October 2023).

The recall was initiated due to deviations from Current Good Manufacturing Practices (CGMP). The company identified violations in its manufacturing processes that did not meet regulatory standards.

The recalled product

Product
Humatrix Microclysmic Gel, 8 oz per bottle, Care-Tech Laboratories, Inc., Saint Louis, Missouri 63139.
Manufacturer
Consolidated Chemical, Inc
Category
Drug
Hazard
  • manufacturing-deviation

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot
  • expiry: Lot 3216
  • exp 04/23 and 3218
  • exp 10/23

Distribution

Distributed nationwide across the United States.

Related recalls

Same category